Search

everythinglearnresearchcommunity

for

Search:↓

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.